Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Inogen Sees Q2 Sales $89.000M-$91.000M vs $92.73M Est

Author: Benzinga Newsdesk | May 07, 2025 04:21pm

Inogen (NASDAQ:INGN) sees Q2 sales of $89.000 million-$91.000 million vs $92.73 million analyst estimate.

Posted In: INGN